Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and

M A Mesquita1, E P Balbino, R S Albuquerque

  • 1Department of Medicine, University of Campinas, Brazil.

Hepato-Gastroenterology
|November 14, 1997
PubMed
Abstract

Insights

Ceftriaxone effectively treats spontaneous bacterial peritonitis (SBP) in cirrhotic patients, reducing ascitic fluid polymorphonuclear cells and improving prognosis. Hospital mortality was linked to specific complications and PMN levels during treatment.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Spontaneous bacterial peritonitis (SBP) is a serious complication in cirrhotic patients.
  • Alcohol-induced cirrhosis and advanced Child-Pugh Class C were common in the study population.
  • Understanding SBP treatment response and mortality factors is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of Ceftriaxone in treating SBP in cirrhotic patients.
  • To assess the ascitic fluid polymorphonuclear (PMN) response to Ceftriaxone therapy.
  • To identify factors associated with hospital mortality in SBP patients.

Main Methods:

  • A study of 62 cirrhotic patients diagnosed with SBP.
  • Treatment with Ceftriaxone (1g every 12 hours).
  • Ascitic fluid analysis, including PMN counts, on admission, day 4, and day 10.

Main Results:

  • Ceftriaxone treatment led to a significant decrease in ascitic fluid PMN counts.
  • 33% of patients achieved PMN counts below 250 cells/mm3 within 4 days.
  • Hospital mortality rate was 24%, associated with gastrointestinal hemorrhage, hepatic encephalopathy, renal failure, and day 4 PMN count.

Conclusions:

  • Ceftriaxone is a safe and effective antibiotic for treating SBP in cirrhotic patients.
  • Early reduction in ascitic fluid PMN count may correlate with improved outcomes.
  • Factors like hemorrhage, encephalopathy, and renal failure significantly impact mortality.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.